Modular Medical's fresh research confirms what clinicians have long suspected: the "almost-pumper" market is enormous, underserved, and apparently very, very tired of injecting insulin in parking lots.
A Number Worth Repeating: 97%
In the often-cautious world of medical device commercialization, where product…
Wall Street has seen its share of big bets, but few are as audacious—or as delightfully bureaucratic—as ITER, the sprawling fusion experiment rising in the south of France. This public‑sector “artificial sun” carries a price tag north of €22 billion, a construction…
U.S. equities extended gains on Tuesday, July 14, 2026, with growth and AI‑linked names leading as cooler‑than‑expected inflation data reinforced expectations that the Federal Reserve is inching closer to a 2026 rate‑cut cycle.
Index recap and closing levels
U.S. markets closed higher…
Humanoid robots recently scrubbed in at UC San Diego and successfully removed gallbladders from live pigs, marking a world‑first teleoperated surgical milestone that investors in robotics, AI, and med‑tech will want on their radar.
When Wall Street Meets the Operating Room
For…
The FT film argues that India’s tech model is being rewired by AI, with data annotation, robot training, and global capability centers replacing the old back-office script, while Indian IT services still carry major export weight and now face both risk and…
Wall Street is treating artificial intelligence less like a bubble and more like a new asset class, and the early winners—from SoftBank to NVIDIA to Apple to IBM—are already writing the opening chapter of what looks increasingly like a durable profit supercycle.
The Gospel According to Masayoshi Son
In…
A San Diego upstart armed with FDA clearance, first commercial shipments, and an audacious two-part pump design is stepping into a multi-billion-dollar market that the industry's giants have repeatedly fumbled
The Patient Nobody Wanted to Build For
For decades, the diabetes device…
U.S. stocks traded with a cautious, slightly risk‑off tone on Monday, July 13, 2026, as investors weighed Middle East tensions, upcoming earnings, and the next batch of inflation data, while select healthcare, industrial, and media names saw idiosyncratic moves.
Market overview…
Agenus Inc. (NASDAQ: AGEN) and Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX, TSX: EPRX) just offered Wall Street a reminder that in biotech, capital and human capital still set the tempo—one via an oversubscribed private placement, the other via a board refresh that reads…
AI isn’t just knocking on the data center door anymore; it is wiring the building, staffing the call center, and quietly re‑pricing entire sectors for investors. From Meta Platforms (NASDAQ: META) in Louisiana to Doximity (NYSE: DOCS), Amwell (NYSE: AMWL), Similarweb (NYSE:…
